US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Commerzbank AG (1CBK) 銘柄情報

Commerzbank AG (1CBK)

0.00

0.00

( 0.00% )

更新日時： -

Commerzbank AG (1CBK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

26.33 52 週間の範囲 38.35

時価総額

前日終値

-

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,291,985 €

発行済株式数

1,080,847,095

配当利回り

1.1 (3.10%)

PER

17.1

1 株当たり利益 (EPS)

2.15

歳入

11.6B

純利益

2.7B

Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, and Asia. It operates through two segments, Private and Small-Business Custome... Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, and Asia. It operates through two segments, Private and Small-Business Customers, and Corporate Clients. The company offers current, money market, checking, business accounts; insurance products; credit and debit cards; pension scheme; card payment terminal; and various loans. It also offers installment loans; renovation loans, debt structuring, car loan, overdraft facility; real estate financing; term deposits; and online banking services, as well as trades securities, such as shares, funds, ETFs, certificates, options and futures, and bonds. In addition, the company provides wealth management services. Commerzbank AG was founded in 1870 and is headquartered in Frankfurt am Main, Germany. 詳細を表示

セクター

Finance

業界

Banking

ウェブサイト

www.commerzbank.de

本社

Frankfurt Am Main, Germany

設立

1870

Commerzbank AG is listed in the Finance sector of the イタリア証券取引所 with ticker 1CBK. The last closing price for Commerzbank was -. Over the last year, Commerzbank shares have traded in a share price range of 26.33 € to 38.35 €.

Commerzbank currently has 1,080,847,095 shares in issue. Commerzbank has a price to earnings ratio (PE ratio) of 17.10.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	36.72	37.43	36.72	4022	37.1261549	DE
4	0	0	36.57	38.14	35.5	8440	36.86823207	DE
12	0	0	31.63	38.14	29.91	8433	35.40975058	DE
26	0	0	35.3	38.14	29.37	7386	34.729513	DE
52	0	0	28.09	38.35	26.33	9365	33.51951309	DE
156	0	0	9.962	38.35	9.1	7160	23.38503905	DE
260	0	0	6.323	38.35	5.018	5975	18.76823584	DE

1CBK - Frequently Asked Questions (FAQ)

What is the current Commerzbank AG share price?

The current share price of Commerzbank AG is 0.00 €

How many Commerzbank AG shares are in issue?

Commerzbank AG has 1,080,847,095 shares in issue

What is the 1 year trading range for Commerzbank AG share price?

Commerzbank AG has traded in the range of 26.33 € to 38.35 € during the past year

What is the PE ratio of Commerzbank AG?

The price to earnings ratio of Commerzbank AG is 17.1

What is the cash to sales ratio of Commerzbank AG?

The cash to sales ratio of Commerzbank AG is 3.43

What is the registered address of Commerzbank AG?

The registered address for Commerzbank AG is Kaiserplatz, Frankfurt am Main, Hessen, 60311

What is the Commerzbank AG website address?

The website address for Commerzbank AG is www.commerzbank.de

Which industry sector does Commerzbank AG operate in?

Commerzbank AG operates in the Banking sector

1kgwxman

1kgwxman 9秒前

Read it again...he's presenting scientific information way above both our mathematical skill levels.
(And I have a math minor with calculus and differential equations under my belt.)

mascale

mascale 2分前

UK spend last year, US spend this year: Happening.

shoondale

shoondale 2分前

Haven't people been fleeced, bilked, and ripped off enough by this scam by now? It's no different than sending these poor Kongs to the Tappan Zee bridge to tell the toll booth operators they have arrived to collect their money because they purchased the bridge...
https://www.azquotes.com/pict

WandererHero90

WandererHero90 2分前

Wow! Thanks Mdk1! This paper is one of the strongest pieces of third-party technical validation of Perkinamine that we've seen in peer-reviewed literature. A "Top Scored Paper" in JLT, from ETH Zurich (one of the world's elite photonics research institutions), demonstrating 400G+ per lane across fou

Monksdream

Monksdream 2分前

TOP 15
https://www.advfn.com/markets/nasdaq/premarket

John von

John von 3分前

Pop the champagne

ScottishTexan

ScottishTexan 3分前

About the only good thing. They're going to have to be real communicative with investors if they want to salvage anything here. Otherwise investors will run for the hills.

1kgwxman

1kgwxman 3分前

Low bar??? 😆😆😆

John von

John von 3分前

These were the two big indigenous tribes. Smaller tribes will probably participate after the fact. The company always stated they don’t need 100% of the tribes to approve, just a majority.

axelvento

axelvento 3分前

mRNA-based influenza vaccine expands the B cell response breadth in humans

https://www.nature.com/articles/s41590-026-02569-5

DayofReckoning

DayofReckoning 3分前

99% of them .. not marrying the stock but thanks for the insight

tdbowieknife

tdbowieknife 3分前

Will Brandenburg tell them he will have a working 5 MW fusion reactor by end of June???

Lol...

.

.

Watch your wallet

Buyer Beware
Social Media Promoted Frontload Pump and Dump Share Selling Scam

biotechinvestor1

biotechinvestor1 4分前

Yet another comical post by our Alteogen clown! Halozyme’s last deal (May 2026) was with GSK. Is that a “junk company” in your view? Pfizer selected a new non-disclosed therapy to be combined with Enhanze just in the last quarter. Have you heard of Pfizer?!!!
With your last post, you lost the

ttottip

ttottip 5分前

Money can be made here.

mascale

mascale 5分前

Diverse projects spend: Creating newsy credibility.

TheRealMrPirate

TheRealMrPirate 5分前

$TWOH "Manageable", if the company was turning a health net profit to support it.
We are talking - "billions" - of shares.
In it's current form it's just another OTC pile of 💩_ _ _ _ pump share selling scam.

Trooperstocks

Trooperstocks 5分前

$BURU “As we continue progressing toward full ownership of Orbit, we believe the platform can serve as a key software foundation supporting the broader expansion of NUBURU’s integrated Defense & Security strategy. The commercial-offer visibility we are seeing across mission-critical customers furthe

tdbowieknife

tdbowieknife 5分前

Oh boy!! Lol!

This ICOPS “invitation” PR is not the validation milestone AMFN wants retail investors to believe it is. It is a low-bar academic conference presentation slot, not a peer-reviewed endorsement, not a scientific acceptance of Texatron physics, and not evidence that Bra

Ask$lapper

Ask$lapper 5分前

Trooperstocks

Trooperstocks 5分前

$BURU “As we continue progressing toward full ownership of Orbit, we believe the platform can serve as a key software foundation supporting the broader expansion of NUBURU’s integrated Defense & Security strategy. The commercial-offer visibility we are seeing across mission-critical customers furthe

Mrt33

1kgwxman

1kgwxman 6分前

Oh snap!!! Either AMFN is for real or they're going to bamboozle the IEEE Nuclear and Plasma Sciences Society (NPSS).
Not a tough decision to figure out truth from anonymous fiction!

FINRA WAS RIGHT!!!
🚀💰🎫🍿

x993231

x993231 7分前

We already authorized it, but it was a rough road, if my memory serves me right in 2007 the shareholders voted against increasing the available shares.

As a result Laurio resigned, I can still see him shaking his head back and forth as the vote was read because obviosly the board had

glenn1919

glenn1919 8分前

IMCC.....HITI.....PAVS.....SUGP.....CRVO.....GDHG....QTEX................................................https://stockcharts.com/sc3/ui/?s=SPCX&p=d&yr=0&mn=2&dy=12&id=p84071410134

Invesco RAFI Emerging Ma...

Cache Exploration

Malteries Franco Belges

Fica Empreendimentos Imo... ON

iShares Global High Yiel...

Anheuser Busch InBev NV

Euronext USA Total Market

Granite Ridge Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。